Cited by 357Cardiovascular Health and Disease PreventionNitric Oxide and Endothelin EffectsAcute Myocardial Infarction Research

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

L-Arginine Therapy in Acute Myocardial Infarction: The Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) Randomized Clinical Trial

Schulman, Steven P., Becker, Lewis C., Kass, David A., Champion, Hunter C., Terrin, Michael L., Forman, Sandra, Ernst, Kavita V., Kelemen, Mark D., Townsend, Susan N., Capriotti, Anne, Hare, Joshua M., Gerstenblith, Gary·2006·JAMA

DOI 10.1001/jama.295.1.58

Open this paper in CoChat — free account

Abstract

CONTEXT: The amino acid L-arginine is a substrate for nitric oxide synthase and is increasingly used as a health supplement. Prior studies suggest that L-arginine has the potential to reduce vascular stiffness. OBJECTIVE: To determine whether the addition of L-arginine to standard postinfarction therapy reduces vascular stiffness and improves ejection fraction over 6-month follow-up in patients following acute ST-segment elevation myocardial infarction. DESIGN AND SETTING: Single-center, randomized, double-blind, placebo-controlled trial with enrollment from February 2002 to June 2004. PATIENTS: A total of 153 patients following a first ST-segment elevation myocardial infarction were enrolled; 77 patients were 60 years or older. INTERVENTION: Patients were randomly assigned to receive L-arginine (goal dose of 3 g 3 times a day) or matching placebo for 6 months. MAIN OUTCOME MEASURES: Change in gated blood pool-derived ejection fraction over 6 months in patients 60 years or older randomized to receive L-arginine compared with those assigned to receive placebo. Secondary outcomes included change in ejection fraction in all patients enrolled, change in noninvasive measures of vascular stiffness, and clinical events. RESULTS: Baseline characteristics, vascular stiffness measurements, and left ventricular function were similar between participants randomized to receive placebo or L-arginine. The mean (SD) age was 60 (13.6) years; of the participants, 104 (68%) were men. There was no significant change from baseline to 6 months in the vascular stiffness measurements or left ventricular ejection fraction in either of the 2 groups, including those 60 years or older and the entire study group. However, 6 participants (8.6%) in the L-arginine group died during the 6-month study period vs none in the placebo group (P = .01). Because of the safety concerns, the data and safety monitoring committee closed enrollment. CONCLUSIONS: L-arginine, when added to standard postinfarction therapies, does not improve vascular stiffness measurements or ejection fraction and may be associated with higher postinfarction mortality. L-arginine should not be recommended following acute myocardial infarction. Clinical Trial Registration ClinicalTrials.gov, NCT00051376.

Integrity signals

Registry

Crossref · 10.1001/jama.295.1.58

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
Pfeffer, M. A., & Braunwald, E. (1990) · Circulation · doi:10.1161/01.cir.81.4.1161 · Cited by 2,874
Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary Arteries
Ludmer, P. L., Selwyn, A. P., Shook, T., Wayne, R. R., Mudge, G. H., Alexander, R. W., & Ganz, P. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610233151702 · Cited by 2,422
Hemodynamic Patterns of Age-Related Changes in Blood Pressure: The Framingham Heart Study
Franklin, S. S., Gustin, W., Wong, N. D., Larson, M. G., Weber, M. A., Kannel, W. B., & Levy, D. (1997) · Circulation · doi:10.1161/01.cir.96.1.308 · Cited by 2,321
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part I: Aging Arteries: A “Set Up” for Vascular Disease
Lakatta, E. G., & Levy, D. (2003) · Circulation · doi:10.1161/01.cir.0000048892.83521.58 · Cited by 2,244
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
Vallance, P., Collier, J., & Moncada, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91013-1 · Cited by 1,590
Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women
Celermajer, D. S., Sørensen, K. E., Spiegelhalter, D. J., Georgakopoulos, D., Robinson, J. T. C., & Deanfield, J. E. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90305-0 · Cited by 1,354
Estimation of Central Aortic Pressure Waveform by Mathematical Transformation of Radial Tonometry Pressure: Validation of Generalized Transfer Function
Chen, C.-H., Nevo, E., Fetics, B., Pak, P. H., Yin, F. C. P., Maughan, W. L., & Kass, D. A. (1997) · Circulation · doi:10.1161/01.cir.95.7.1827 · Cited by 1,307
Self-citation
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises
Lakatta, E. G., & Levy, D. A. (2003) · Circulation · doi:10.1161/01.cir.0000048893.62841.f7 · Cited by 1,257
Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults
Sutton-Tyrrell, K., Najjar, S. S., Boudreau, R. M., Venkitachalam, L., Kupelian, V. A., Simonsick, E. M., Havlik, R. J., Lakatta, E. G., Spurgeon, H. A., Kritchevsky, S. B., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.483628 · Cited by 1,250
Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction: Its Role in Hypercholesterolemia
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease
Mancini, G. B. J., Henry, G. C., Macaya, C., O’Neill, B. J., Pucillo, A. L., Carere, R. G., Wargovich, T. J., Mudra, H. G., Lüscher, T. F., Klibaner, M. I., et al. (1996) · Circulation · doi:10.1161/01.cir.94.3.258 · Cited by 1,056
Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China.
Avolio, A. P., Deng, F. Q., Li, W. Q., Luo, Y., Huang, Z., Xing, L. F., & O’Rourke, M. F. (1985) · Circulation · doi:10.1161/01.cir.71.2.202 · Cited by 838
Effective arterial elastance as index of arterial vascular load in humans.
Kelly, R. P., Ting, C.-T., Yang, T. M., Liu, C. P., Maughan, W. L., Chang, M.-S., & Kass, D. A. (1992) · Circulation · doi:10.1161/01.cir.86.2.513 · Cited by 832
Self-citation
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.
Sutton, M. S. J., Pfeffer, M. A., Plappert, T. A., Rouleau, J. L., Moyé, L. A., Dagenais, G. R., Lamas, G. A., Klein, M., Sussex, B. A., & Goldman, S. (1994) · Circulation · doi:10.1161/01.cir.89.1.68 · Cited by 821
Aging and Endothelial Function in Normotensive Subjects and Patients With Essential Hypertension
Taddei, S., Virdis, A., Mattei, P., Ghiadoni, L., Gennari, A., Fasolo, C. B., Sudano, I., & Salvetti, A. (1995) · Circulation · doi:10.1161/01.cir.91.7.1981 · Cited by 718
Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.
Hochman, J. (2003) · Circulation · doi:10.1161/01.cir.0000075927.67673.f2 · Cited by 622
Sphygmomanometrically Determined Pulse Pressure Is a Powerful Independent Predictor of Recurrent Events After Myocardial Infarction in Patients With Impaired Left Ventricular Function
Mitchell, G. F., Moyé, L. A., Braunwald, E., Rouleau, J. L., Bernstein, V., Geltman, E. M., Flaker, G. C., Pfeffer, M. A., & for the SAVE Investigators (1997) · Circulation · doi:10.1161/01.cir.96.12.4254 · Cited by 527
Nitric Oxide Regulates Local Arterial Distensibility In Vivo
Wilkinson, I. B., Qasem, A., McEniery, C. M., Webb, D. J., Avolio, A. P., & Cockcroft, J. R. (2002) · Circulation · doi:10.1161/hc0202.101970 · Cited by 502
Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels
Berkowitz, D. E., White, R., Li, D., Minhas, K. M., Cernetich, A., Kim, S., Burke, S., Shoukas, A. A., Nyhan, D., Champion, H. C., et al. (2003) · Circulation · doi:10.1161/01.cir.0000092948.04444.c7 · Cited by 486
Self-citation
Oxidant stress from nitric oxide synthase–3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load
Takimoto, E., Champion, H. C., Li, M., Ren, S. V., Rodríguez, E. R., Tavazzi, B., Lazzarino, G., Paolocci, N., Gabrielson, K. L., Wang, Y., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci21968 · Cited by 446
Self-citation
Long-term l -Arginine Supplementation Improves Small-Vessel Coronary Endothelial Function in Humans
Lerman, A., Burnett, J. C. J., Higano, S. T., McKinley, L. J., & Holmes, D. R. (1998) · Circulation · doi:10.1161/01.cir.97.21.2123 · Cited by 426
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty.
Mark, D. B., Nelson, C. L., Califf, R. M., Harrell, F. E., Lee, K., Jones, R. H., Fortin, D. F., Stack, R. S., Glower, D. D., & Smith, L. (1994) · Circulation · doi:10.1161/01.cir.89.5.2015 · Cited by 420
Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.
Clarkson, P., Adams, M. R., Powe, A. J., Donald, A. E., McCredie, R. J., Robinson, J. T. C., McCarthy, S., KEECH, A. C., Celermajer, D. S., & Deanfield, J. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118632 · Cited by 408
Age-Related Increase in Mortality among Patients with First Myocardial Infarctions Treated with Thrombolysis
Maggioni, A. P., Maseri, A., Fresco, C., Franzosi, M. G., Mauri, F., Santoro, E., & Tognoni, G. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292002 · Cited by 395
Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox
Lee, J.-H., Ryu, H., Ferrante, R. J., Morris, S. M., & Ratan, R. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0735876100 · Cited by 365
Estimation of Central Aortic Pressure Waveform by Mathematical Transformation of Radial Tonometry Pressure Data
Lehmann, E. D. (1998) · Circulation · doi:10.1161/01.cir.98.2.186 · Cited by 353
Ventriculoarterial coupling in normal and failing heart in humans.
Asanoi, H., Sasayama, S., & Kameyama, T. (1989) · Circulation Research · doi:10.1161/01.res.65.2.483 · Cited by 348
The Clinical Pharmacology of L-Arginine
Böger, R. H., & Bode‐Böger, S. M. (2001) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.79 · Cited by 337
Endothelial dysfunction: Clinical implications
Drexler, H. (1997) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(97)80030-8 · Cited by 291
Randomized, Double-Blind, Placebo-Controlled Study of Supplemental Oral l -Arginine in Patients With Heart Failure
Rector, T. S., Bank, A. J., Mullen, K. A., Tschumperlin, L. K., Sih, R. T., Pillai, K., & Kubo, S. H. (1996) · Circulation · doi:10.1161/01.cir.93.12.2135 · Cited by 275
Age and Outcome With Contemporary Thrombolytic Therapy
White, H. D., Barbash, G. I., Califf, R. M., Simes, R. J., Granger, C. B., Weaver, W. D., Kleiman, N. S., Aylward, P. E., Gore, J. M., Vahanian, A. S., et al. (1996) · Circulation · doi:10.1161/01.cir.94.8.1826 · Cited by 273
Regulation of Enzymes of Urea and Arginine Synthesis
Morris, S. M. (1992) · Annual Review of Nutrition · doi:10.1146/annurev.nu.12.070192.000501 · Cited by 252
Age and Gender Affect Ventricular-Vascular Coupling During Aerobic Exercise
Najjar, S. S., Schulman, S. P., Gerstenblith, G., Fleg, J. L., Kass, D. A., O'Connor, F., Becker, L. C., & Lakatta, E. G. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.04.041 · Cited by 183
Self-citation
Oral l-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease
Adams, M. R., McCredie, R. J., Jessup, W., Robinson, J. T. C., SULLIVAN, D. R., & Celermajer, D. S. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06044-3 · Cited by 181
Effects of HMG-CoA Reductase Inhibitors on Endothelial Function: Role of Microdomains and Oxidative Stress
Mason, R. P., Walter, M. F., & Jacob, R. F. (2004) · Circulation · doi:10.1161/01.cir.0000129503.62747.03 · Cited by 175
Aging-Associated Endothelial Dysfunction in Humans Is Reversed by L-Arginine
Chauhan, A., More, R. S., Mullins, P. A., Taylor, G., Petch, M. C., & Schofield, P. M. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00394-4 · Cited by 174
Worst-Rank Score Analysis with Informatively Missing Observations in Clinical Trials
Lachin, J. M. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00022-7 · Cited by 164
Direct Effects of Smooth Muscle Relaxation and Contraction on In Vivo Human Brachial Artery Elastic Properties
Bank, A. J., Wilson, R. F., Kubo, S. H., Holte, J. E., Dresing, T., & Wang, H. (1995) · Circulation Research · doi:10.1161/01.res.77.5.1008 · Cited by 163
Oral l -Arginine in Patients With Coronary Artery Disease on Medical Management
Blum, A., Hathaway, L., Mincemoyer, R., Schenke, W. H., Kirby, M., Csákó, G., Waclawiw, M. A., Panza, J. A., & Cannon, R. O. (2000) · Circulation · doi:10.1161/01.cir.101.18.2160 · Cited by 162
Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases.
Cooke, J. P., & Dzau, V. J. (1997) · PubMed · Cited by 138
Aortic compliance in human hypertension.
Liu, Z. R., Ting, C.-T., Zhu, S., & Yin, F. C. P. (1989) · Hypertension · doi:10.1161/01.hyp.14.2.129 · Cited by 116
L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
Böger, R. H., & Ron, E. S. (2005) · PubMed · Cited by 112
Effects of Chronic Treatment With l -Arginine on Atherosclerosis in ApoE Knockout and ApoE/Inducible NO Synthase Double-Knockout Mice
Chen, J., Kuhlencordt, P. J., Urano, F., Ichinose, H., Astern, J., & Huang, P. L. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000040223.74255.5a · Cited by 95
Relation between ventriculoarterial coupling and myocardial energetics in patients with idiopathic dilated cardiomyopathy
Ishihara, H., Yokota, M., Sobue, T., & Saito, H. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90428-6 · Cited by 86
What We Know and Don’t Know About l -Arginine and NO
Loscalzo, J. (2000) · Circulation · doi:10.1161/01.cir.101.18.2126 · Cited by 85
Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators.
Aguirre, F. V., McMahon, R. P., Mueller, H., Kleiman, N. S., Kern, M. J., Desvigne-Nickens, P. M., Hamilton, W. P., & CHAITMAN, B. R. (1994) · Circulation · doi:10.1161/01.cir.90.1.78 · Cited by 63
Adverse Effects of Supplemental l -Arginine in Atherosclerosis
Loscalzo, J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000040860.71626.9d · Cited by 59
The plasma flux and oxidation rate of ornithine adaptively decline with restricted arginine intake.
Castillo, L., Mendiola, M. S., Chapman, T. E., Ajami, A. M., Burke, J. F., & Young, V. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6393 · Cited by 57
Prevalence of leading types of dietary supplements used in the Third National Health and Nutrition Examination Survey, 1988--94.
Ervin, R. B., Wright, J. D., & Reed-Gillette, D. (2004) · PubMed · Cited by 49
Improving the information content of categorical clinical trial endpoints
Berger, V. W. (2002) · Controlled Clinical Trials · doi:10.1016/s0197-2456(02)00233-7 · Cited by 46
Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction
Schulman, S. P., Weiss, J. L., Becker, L. C., Guerci, A. D., Shapiro, E. P., CHANDRA, N. C., SIU, C. O., Flaherty, J. T., Coombs, V. J., Taube, J. C., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80223-9 · Cited by 34
Self-citation
L-Arginine in the Management of Cardiovascular Diseases
Cheng, J. W. M., & Balwin, S. N. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.10216 · Cited by 27
Oral L-arginine (and other active ingredients) for ischemic heart disease?∗∗Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
Cannon, R. O. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01693-x · Cited by 6

Sorted by citations

Strategies to increase nitric oxide signalling in cardiovascular disease
Lundberg, J. O., Gladwin, M. T., & Weitzberg, E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4623 · Cited by 576
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Pharmacokinetic and pharmacodynamic properties of oral L‐citrulline and L‐arginine: impact on nitric oxide metabolism
Schwedhelm, E., Maas, R., Freese, R., Jung, D., Lukacs, Z., Jambrecina, A., Spickler, W., Schulze, F., & Böger, R. H. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02990.x · Cited by 494
Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets?
Rochette, L., Lorin, J., Zeller, M., Guilland, J.-C., Lorgis, L., Cottin, Y., & Vergely, C. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.07.004 · Cited by 456
Nutrition, physical activity, and cardiovascular disease: An update
IGNARRO, L., Balestrieri, M. L., & Claudio Napoli, A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.06.030 · Cited by 454

See all 357

Authors: Schulman, S. P., Becker, L. C., Kass, D. A., Champion, H. C., Terrin, M. L., Forman, S., Ernst, K. V., Kelemen, M. D., Townsend, S. N., Capriotti, A., Hare, J. M., & Gerstenblith, G.
Affiliations: Johns Hopkins University (US)
University of Maryland, Baltimore (US)
Maryland Medical Research Institute (US)
Corresponding author: Schulman, Steven P.
ORCID: Schulman, Steven P.
Becker, Lewis C.
Kass, David A.
Terrin, Michael L.
Hare, Joshua M.
Gerstenblith, Gary
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2006-01-04
Volume: 295
Issue: 1
Pages: 58
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.295.1.58
OpenAlex: W2112439550
Cited by: 357
References: 54
Citations by year: 2026: 12 · 2025: 8 · 2024: 7 · 2023: 10 · 2022: 14 · 2021: 9 · 2020: 13 · 2019: 13 · 2018: 18 · 2017: 20 · 2016: 22 · 2015: 19 · 2014: 18 · 2013: 22 · 2012: 21
FWCI: 19.67
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01hl070059-04)
National Heart, Lung, and Blood Institute (HL70059)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Keywords: L-arginine, acute myocardial infarction, ST-elevation myocardial infarction, vascular stiffness, left ventricular ejection fraction, nitric oxide synthase, mortality, older adults, dietary supplementation
MeSH terms: Aged, Arginine, Double-Blind Method, Female, Humans, Male, Middle Aged, Myocardial Infarction, Stroke Volume, Ventricular Function, Left, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

L-Arginine Therapy in Acute Myocardial Infarction: The Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) Randomized Clinical Trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks